Fertility Benefits Manager Progyny Soars 23% in Nasdaq Debut

Progyny, which manages fertility benefits for employees at large self-insured companies, made is debut on the Nasdaq. Shares of the company opened for trading at $13.50, compared to an IPO price of $13. Lisa Greenbaum, Chief Client Officer at Progyny, joined to discuss.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.